Rasio rega marang bathi BioLife Solutions Inc (BLFS)
Despite a prolonged downturn in the cell therapy sector, BioLife Solutions, Inc. (BLFS) is entering a growth phase. Internal resilience is based on a closed ecosystem of FDA-approved tools, making a change of supplier critical. The P/E ratio history demonstrates valuation dynamics, where the parameter value equals 40.30. Strategic management solidifies the company's status as a key link in biomaterial logistics for the entire industry.
Rincian analitis perusahaan BioLife Corp (BLFS)
- rega pasar lan target rega analis:
- rincian kapitalisasi pasar:
- informasi kapitalisasi buku:
- informasi babagan utang lan solvabilitas:
Utang marang Modal BioLife Solutions, Inc.|BLFS - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal BioLife|BLFS - Utang perusahaan|Utang-utang marang aset resik BioLife Solutions, Inc.|BLFS - Utang jangka dawa perusahaan|Utang jangka cendhak BioLife Solutions|Likuiditas cepet biolifesolutions.com
- rincian bathi lan kelipatan pasar:
BLFS - Penghasilan resik|Proyeksi bathi mangsa ngarep BioLife Solutions, Inc.|BLFS - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep BioLife Solutions Inc|BLFS - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan BioLife Solutions, Inc.|BLFS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan BioLife Solutions|BLFS - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan biolifesolutions.com|BLFS - Wutah bathi saben saham ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep BioLife Solutions, Inc.
Analisis komprehensif perusahaan:BioLife Solutions, Inc.
The P/E ratio reflects the market value of a business relative to its net income, allowing an investor to assess the premium paid for future earnings and compare the asset with industry peers. By analyzing the estimated P/E of the company, one can determine the investment attractiveness of BioLife Solutions, Inc. (BLFS) as a critical logistics operator in the regenerative medicine and cell therapy segment.
Analisis perusahaan pesaing
Kapitalisasi marang bathi Tempus AI Inc TEM|Rasio rega marang bathi Qiagen (QGEN)|Rasio rega marang bathi IONS (Ionis Pharmaceuticals, Inc.)|Pangali P/E RGEN (Repligen Corp.)|Periode bali modal bisnis Avidity Corp (RNA)|CRISPR Therapeutics AG - Pangali P/E|Kapitalisasi marang bathi resik WGS|RARE: Pangali P/E|Kapitalisasi marang bathi Beam Therapeutics Inc (BEAM)|Koefisien rega marang bathi SRPT|TWST: Nilai perusahaan marang bathi resik|Rasio rega marang bathi 10x Genomics, Inc. (TXG)|Periode bali modal bisnis intelliatx.com|Rasio rega marang bathi Stoke Therapeutics, Inc. STOK|Wave Life Sciences Ltd (WVE) - Kapitalisasi marang bathi|MAZE - Rasio rega marang bathi|SION: Rasio rega marang bathi|PRME (Prime Medicine, Inc.) - Koefisien rega marang bathi|tayshagtx.com (TSHA) - Pangali P/E|Koefisien rega marang bathi QURE|MGTX (MeiraGTx Holdings) - Rasio rega pasar marang bathi resik|Pangali P/E RGNX|Periode bali modal bisnis Solid Corp|Rasio rega marang bathi Ocugen, Inc. OCGN|pacb.com (PACB) - Kapitalisasi marang bathi|BNTC - Rasio rega marang bathi|DSGN (Design Therapeutics Inc) - Pangali rega marang bathi|Rocket Pharmaceuticals Inc (RCKT) - Rasio rega marang bathi|FDMT - Periode bali modal bisnis|Koefisien rega marang bathi LXEO|KRRO: Nilai perusahaan marang bathi resik|Pangali P/E EDIT|Periode bali modal bisnis Silence Therapeutics PLC|Rasio rega marang bathi ProQR Therapeutics PRQR|CDXS: Pangali rega marang bathi|Sangamo Therapeutics - Pangali P/E|Nautilus Biotechnology (NAUT) - Koefisien rega marang bathi|MGX (Metagenomi) - Koefisien rega marang bathi|DTIL - Periode bali modal bisnis|GBIO (Generation Bio Co) - Pangali P/E|Rasio rega marang bathi BOLD|Rasio rega marang bathi Exicure, Inc. (XCUR)|Rasio rega marang bathi IMNN (imunon.com)|Pangali P/E PHIO (Phio Pharmaceuticals Corp.)|MBIO (Mustang Bio Inc) - Kapitalisasi marang bathi resik|RNAZ - Rasio rega marang bathi|Periode bali modal bisnis Bionano Genomics, Inc. BNGO|APDN: Pangali P/E|Pangali rega marang bathi BLUE|Rasio rega marang bathi ImmunoPrecise Antibodies Ltd|Pangali rega marang bathi OMGA (Omega Therapeutics Inc)|Pangali P/E OMIC|Pangali P/E Regulus (RGLS)|Pangali P/E SYRS (Syros Pharmaceuticals)|telesisbio.com - Rasio rega marang bathi|TRACON Pharmaceuticals, Inc. - Pangali P/E|Periode bali modal bisnis Unity Biotechnology Inc. UBX
